SCHEMBL20323720

SCHEMBL20323720

C[C@@H]1CCCC(CN(C)C)C1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.32
ADRA1B P35368 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21950092 0.86 TRPA1 (0.32)
SCHEMBL19559238 0.86 TRPA1 (0.32)
SCHEMBL21698742 0.86 TRPA1 (0.32)
SCHEMBL8368347 0.85 SIGMAR1 (0.37) SIGMAR1ADRA1B
SCHEMBL24393441 0.81 ACHE (0.40) SIGMAR1ADRA1B
SCHEMBL2076710 0.80
SCHEMBL16559114 0.78 OPRM1 (0.31)
SCHEMBL18348230 0.78
SCHEMBL12849318 0.77 SIGMAR1 (0.32) SIGMAR1ADRA1B
SCHEMBL5687213 0.77 SIGMAR1 (0.32) SIGMAR1ADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022047145-A1 RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2022-03-03 WO disclosed
WO-2019199816-A1 CEREBLON LIGANDS AND BIFUNCTIONAL COMPOUNDS COMPRISING THE SAME ARVINAS OPERATIONS, INC. (US) 2019-10-17 WO disclosed
WO-2018119448-A1 COMPOUNDS AND METHODS FOR THE TARGETED DEGRADATION OF RAPIDLY ACCELERATED FIBROSARCOMA POLYPEPTIDES Arvinas, Inc. (US) 2018-06-28 WO disclosed